BioNTech SE (BNTX)
86.11
-0.39
(-0.45%)
USD |
NASDAQ |
Jun 10, 14:50
BioNTech Profit Margin (Quarterly) : -450.4% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -345.2% |
| NuCana Plc | -- |
| MediGene AG | -- |
| InflaRx NV | -- |
| Mereo BioPharma Group Plc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.71% |
| Return on Assets | -5.87% |
| Return on Invested Capital | -6.61% |
| Gross Profit Margin (Quarterly) | -63.17% |
| Operating Margin (Quarterly) | -559.8% |
| Return on Net Operating Assets | -29.71% |